Newsletter Owner Verification

cafepharma updates

cafepharma updates · September 21 2026 - CagriSema tops Eli Lilly's tirzepatide for weight loss in late-stage diabetes trial — Pharmaceuticals newsletter ranking. Verify this listing to confirm the newsletter owner.

Verify you're the Newsletter Owner

Confirm you publish cafepharma updates. We'll email you a one-click verification link. Verifying is free and unlocks:

  • Verified badge — confirm that this listing is tied to the correct newsletter owner.
  • Your own sponsor pitch page — a public Sponsor Scout profile linked from your ranking, built to convert sponsor interest.
  • Rank-change alerts — we email you when your position moves.
  • A free Sponsor Scout account — our AI agent finds companies actively sponsoring properties like yours.

Not you? Tell us who leads it

Know who really runs cafepharma updates? Point us to them and we'll reach out to invite them to verify.